Verition Fund Management’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-98,446
Closed -$1.13M 3469
2024
Q3
$1.13M Sell
98,446
-260,739
-73% -$2.97M 0.01% 1801
2024
Q2
$4.05M Hold
359,185
0.02% 848
2024
Q1
$3.99M Hold
359,185
0.03% 812
2023
Q4
$3.94M Buy
359,185
+195,000
+119% +$2.12M 0.03% 534
2023
Q3
$1.77M Hold
164,185
0.02% 839
2023
Q2
$1.75M Hold
164,185
0.02% 731
2023
Q1
$1.72M Hold
164,185
0.02% 746
2022
Q4
$1.68M Hold
164,185
0.03% 691
2022
Q3
$1.64M Buy
+164,185
New +$1.65M 0.02% 1049

Other funds holding RENE

Verition Fund Management's RENE Position: Q4 2024 in Review

Verition Fund Management sold out of Cartesian Growth Corp II (RENE) in Q4 2024, closing a stake of 98,446 shares — an estimated $1.13M sold.

Verition Fund Management first reported a position in RENE in Q3 2022 and held it in 9 quarters. The position peaked at $4.05M in Q2 2024. 19 funds tracked by Wall St. Rank hold RENE as of Q4 2024.

  • Verition Fund Management reported no remaining Cartesian Growth Corp II position as of Q4 2024 after selling out during the quarter.
  • Verition Fund Management sold 98,446 Cartesian Growth Corp II shares in Q4 2024, an estimated $1.13M.
  • Verition Fund Management first reported a position in Cartesian Growth Corp II in Q3 2022 and held it in 9 quarters.
  • Verition Fund Management's Cartesian Growth Corp II position peaked at $4.05M in Q2 2024.
  • 19 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q4 2024.

Based on Verition Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.